Ngm Biopharmaceuticals Inc

CIK 1426332 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ngm Biopharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Apr 15, 202415-12G0000950142-24-001034
Apr 8, 202440000950142-24-000999
Apr 8, 202440000950170-24-042625
Apr 8, 202440000950170-24-042600
Apr 8, 202440000950170-24-042607
Apr 8, 2024EFFECT9999999995-24-000883
Apr 8, 202440000950170-24-042609
Apr 8, 202440000950142-24-001002
Apr 8, 202440000950170-24-042619
Apr 8, 202440000950170-24-042583
Apr 8, 202440000950170-24-042588
Apr 8, 202440000950170-24-042602
Apr 8, 202440000950170-24-042606
Apr 8, 202440000950142-24-001001
Apr 8, 202440000950170-24-042611
Apr 8, 202440000950142-24-001000
Apr 5, 2024S-8 POS0001193125-24-088131
Apr 5, 2024S-8 POS0001193125-24-088133
Apr 5, 20248-K0001193125-24-088076
Apr 5, 2024S-8 POS0001193125-24-088135
Apr 5, 2024S-8 POS0001193125-24-088129
Apr 5, 202425-NSE0001354457-24-000235
Apr 5, 2024SC 13D/A0000950142-24-000985
Apr 5, 2024SC 14D9/A0001193125-24-088024
Apr 5, 2024SC 13E3/A0001140361-24-018184